Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome
- 30 September 2005
- journal article
- research article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 69 (3), 249-255
- https://doi.org/10.1016/j.diabres.2005.01.005
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a modelBlood Cells, Molecules, and Diseases, 2005
- Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individualsThe American Journal of Cardiology, 2005
- Relation between insulin resistance and hematological parameters in elderly Koreans—Southwest Seoul (SWS) StudyDiabetes Research and Clinical Practice, 2003
- C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular EventsCirculation, 2003
- New aspects of the insulin resistance syndrome: impact on haematological parametersDiabetologia, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Insulin and insulin‐like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptorsBritish Journal of Haematology, 2000
- The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions – comparison to other cytokines and growth factorsLeukemia, 1998
- Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.JCI Insight, 1989
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957